Cargando…

Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response

Radiation therapy (RT) is frequently used to locally treat tumors. One of the major issues in RT is normal tissue toxicity; thus, it is necessary to limit dose escalation for enhanced local control in patients that have locally advanced tumors. Integrating radiosensitizing agents such as gold nanopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Nolan, Alhussan, Abdulaziz, Bromma, Kyle, Jay, David, Donnelly, James C., West, Frederick G., Lavasanifar, Afsaneh, Weinfeld, Michael, Beckham, Wayne, Chithrani, Devika B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783290/ https://www.ncbi.nlm.nih.gov/pubmed/36559288 http://dx.doi.org/10.3390/pharmaceutics14122795

Ejemplares similares

Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin
por: Han, Ocean, et al.
Publicado: (2022)

Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment
por: Bromma, Kyle, et al.
Publicado: (2021)

Docetaxel-Mediated Uptake and Retention of Gold Nanoparticles in Tumor Cells and in Cancer-Associated Fibroblasts
por: Alhussan, Abdulaziz, et al.
Publicado: (2021)

Utilizing Gold Nanoparticles as Prospective Radiosensitizers in 3D Radioresistant Pancreatic Co-Culture Model
por: Alhussan, Abdulaziz, et al.
Publicado: (2023)

Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel
por: Bromma, Kyle, et al.
Publicado: (2023)

Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology
por: Bromma, Kyle, et al.
Publicado: (2020)

Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy
por: Alhussan, Abdulaziz, et al.
Publicado: (2021)

Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer
por: Alhussan, Abdulaziz, et al.
Publicado: (2022)

Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics
por: Jackson, Nolan, et al.
Publicado: (2023)

Advances in Gold Nanoparticle-Based Combined Cancer Therapy
por: Bromma, Kyle, et al.
Publicado: (2020)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
por: Lane, Thomas R., et al.
Publicado: (2019)

Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment
por: Alhussan, Abdulaziz, et al.
Publicado: (2021)

Potential of Gold Nanoparticles in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblasts Cells
por: Alhussan, Abdulaziz, et al.
Publicado: (2022)

Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies
por: Yang, Celina, et al.
Publicado: (2018)

Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel
por: Bromma, Kyle, et al.
Publicado: (2022)

Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models
por: Yang, Celina, et al.
Publicado: (2018)

Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2021)

Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine
por: Kincaid, Joseph R. A., et al.
Publicado: (2022)

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
por: Koehne, Erik, et al.
Publicado: (2022)

Elucidating the fate of nanoparticles among key cell components of the tumor microenvironment for promoting cancer nanotechnology
por: Bromma, Kyle, et al.
Publicado: (2020)

Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics
por: Jelveh, Salomeh, et al.
Publicado: (2011)

Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine
por: Bannister, Aaron, et al.
Publicado: (2020)

Colloidal Gold-Mediated Delivery of Bleomycin for Improved Outcome in Chemotherapy
por: Yang, Celina, et al.
Publicado: (2016)

Old drug repurposing for neglected disease: Pyronaridine as a promising candidate for the treatment of Echinococcus granulosus infections
por: Li, Jun, et al.
Publicado: (2020)

Transcriptome analysis uncovers the key pathways and candidate genes related to the treatment of Echinococcus granulosus protoscoleces with the repurposed drug pyronaridine
por: Yu, Yingfang, et al.
Publicado: (2021)

Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy
por: Sadat, Sams M. A., et al.
Publicado: (2020)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic
por: Krishna, Sanjeev, et al.
Publicado: (2021)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Quantification of the antimalarial drug pyronaridine in whole blood using LC–MS/MS — Increased sensitivity resulting from reduced non-specific binding
por: Blessborn, Daniel, et al.
Publicado: (2017)

Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
por: Rottmann, Matthias, et al.
Publicado: (2020)

Size-Dependent Gold Nanoparticle Interaction at Nano–Micro Interface Using Both Monolayer and Multilayer (Tissue-Like) Cell Models
por: Yohan, Darren, et al.
Publicado: (2015)

Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
por: Morris, Carrie A., et al.
Publicado: (2014)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2020)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2021)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
por: Vignaux, Patricia A., et al.
Publicado: (2023)

Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization
por: McAnally, Danielle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bpvlpp4ra3eu3sacuch95cm68m